Ascendis Pharma A/S - ADR

NASDAQ:ASND

142.67

+1.72 (+1.22%)

4:23:50 PM EDT: $139.90 -2.77 (-1.94%)

Market Cap (Intraday)	8.28B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$93.72 Million
Adjusted EPS	-$1.70

See more estimates

10-Day MA	$143.99
50-Day MA	$135.35
200-Day MA	$137.48

See more pivots

Ascendis Pharma A/S - ADR Stock, NASDAQ:ASND

Tuborg Boulevard 12, Hellerup, Capital Region 2900

Denmark

Phone: +45.70.22.22.44

Number of Employees:

http://www.ascendispharma.com

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.